Leadership Team

The Shionogi Inc. leadership team has decades of combined pharmaceutical and industry experience in developing and commercializing therapeutics.

Focused on Solutions

Since 2011, when Shionogi Inc. was established in the U.S., our leadership team has focused on bringing the benefits of Shionogi’s small molecule drug innovations to U.S. patients through our own efforts and through multiple inventive collaborations. During this period, Shionogi Inc. gained our first two New Chemical Entity (NCE) approvals while reshaping our business around our science-based heritage and core areas of infectious diseases and pain.

Executive Leadership Committee

Akira Kato, Ph.D.

Akira Kato, Ph.D.

President and Chief Executive Officer

Tadashi Hara

Tadashi Hara

Executive Vice President and Chief Financial Officer

Nathan McCutcheon

Nathan McCutcheon

Executive Vice President and Chief Commercial Officer

Joseph Spagnardi

Joseph Spagnardi

Executive Vice President, Legal and Compliance

Senior Leadership Team

Ting Chen

Ting Chen

Senior Vice President, U.S. Regulatory Affairs

Lynn Dale

Lynn Dale

Senior Vice President, Supply Chain

Gianine Esposito

Gianine Esposito

Senior Vice President, Human Resources

James (Jim) Garrison

Vice President, Business Development

Andrew Koren

Vice President, U.S. Medical Affairs

Richard Marino

Richard Marino

Senior Vice President, Quality Assurance and R.A. C.M.C.

Gareth Morgan

Gareth Morgan

Senior Vice President, Head, Global Portfolio Management

Den Nagata M.D.

Den Nagata, M.D.

Senior Vice President, Medical Science and Chief Medical Officer

Portrait of Jonathon Goldman

Jonathon Goldman

Vice President, Global Commercial Strategy

Portrait of Carlos Tessi

Carlos Tessi, M.D.

Vice President, Compliance

Portrait of Takeki Uehara

Takeki Uehara, Ph.D.

Senior Vice President, Clinical Development